Abbott Laboratories did not infringe a New York-based company’s patent on nucleic acid-detection technology because the supplier’s patent is invalid for not adequately explaining itself, a Delaware federal judge ruled.The Lake County-based pharmaceutical company was represented in the case by a group of attorneys from Kirkland & Ellis LLP.Enzo Life Sciences Inc.’s 2012 patent-infringement suit against Abbott alleged infringement of three U.S. patents -- Nos. 7,064,197, 8,097,405 and 6,992,180.Enzo …